Mutant L Homologue 1 (MLH1): A possible new immunohistochemical marker for prostatic cancer [9]

Histopathology

Volumn 52, Issue 2, 2008, Pages 247-250

  Chuang, S T ^a   Adley, B ^a   Han, M ^a   Lin, F ^b   Yang, X J ^a   Catalona, W J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; TUMOR MARKER;

BENIGN TUMOR; CANCER DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; HUMANS; MALE; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 37549028825     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02879.x     Document Type: Letter

References (9)

1. Burmester JK, Suarez BK, Lin JH et al. Analysis of candidate genes for prostate cancer. Hum. Hered. 2004 57 172 178.
2. Strand M, Prolla TA, Liskay RM, Petes TD. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993 365 274 276.
3. Cunningham JM, Shan A, Wick MJ et al. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res. 1996 56 4475 4482.
4. Egawa S, Uchida T, Suyama K et al. Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res. 1995 55 2418 2421.
5. Gao X, Wu N, Grignon D et al. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 1994 9 2999 3003.
6. Yeh CC, Lee C, Dahiya R. DNA mismatch repair enzyme activity and gene expression in prostate cancer. Biochem. Biophys. Res. Commun. 2001 285 409 413.
7. Chen Y, Wang J, Fraig MM et al. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Int. J. Oncol. 2003 22 1033 1043.
8. Chen Y, Wang J, Fraig MM et al. Defects of DNA mismatch repair in human prostate cancer. Cancer Res. 2001 61 4112 4121.
9. Caldes T, Godino J, Sanchez A et al. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep. 2004 12 621 629.